CytoMed Therapeutics Ratios (2021-2025) | GDTC

Ratios Dec2021 Dec2022 Dec2023 Dec2024 Dec2025
Efficiency
Assets Average (Quarter) 4.12M6.46M8.37M6.86M
Equity Average (Quarter) 1.17M4.38M7.56M6.04M
Invested Capital (Quarter) 1.93M0.79M8.66M7.12M5.60M
Leverage & Solvency
Debt to Equity (Quarter) 0.361.370.040.050.06
Debt Ratio (Quarter) 0.150.150.040.040.05
Equity Ratio (Quarter) 0.430.110.910.900.86
Valuation
Enterprise Value (Quarter) -1.85M-1.14M-6.66M-3.74M-1.62M